Search Count: 363
![]() |
Biochemical And Structural Characterization Of A Novel 4-Hydroxyphenylacetate-3-Monooxygenase From Geobacillus Mahadii Geo-05
Organism: Geobacillus mahadia
Method: X-RAY DIFFRACTION Release Date: 2025-09-10 Classification: HYDROLASE Ligands: PEU |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-09-03 Classification: HYDROLASE Ligands: NAG, IMD, EDO, X92, PGE, BO3, CL, ZN |
![]() |
Human Angiotensin-1 Converting Enzyme C-Domain In Complex With Trandolaprilat
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-09-03 Classification: HYDROLASE Ligands: ZN, X93, NAG, PEG, IMD, CL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-09-03 Classification: HYDROLASE Ligands: ZN, A1I5A, IMD, GOL, BO3, EDO, PEG, CL, NA |
![]() |
Human Angiotensin-1 Converting Enzyme C-Domain In Complex With Perindoprilat
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-09-03 Classification: HYDROLASE Ligands: ZN, CL, IMD, EDO, X94, NAG |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-09-03 Classification: HYDROLASE Ligands: ZN, X92, PGE, EDO, ACT, 1PE, CL, MG, CA, NAG, PEG |
![]() |
Human Angiotensin-1 Converting Enzyme N-Domain In Complex With Trandolaprilat
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-09-03 Classification: HYDROLASE Ligands: PG4, ACT, PEG, X93, EDO, PGE, ZN, CL, CA |
![]() |
![]() |
Human Angiotensin-1 Converting Enzyme N-Domain In Complex With Perindoprilat
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-09-03 Classification: HYDROLASE Ligands: ZN, NAG, PG4, EDO, PGE, PEG, X94, CL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-09-03 Classification: HYDROLASE Ligands: ZN, PG4, PEG, PGE, EDO, EAL, CL, NAG, CA |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ISOMERASE Ligands: ACT |
![]() |
Alpha-Methylacyl-Coa Racemase From Mycobacterium Tuberculosis In Complex With Ibuprofenoyl-Coa
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ISOMERASE Ligands: SFC |
![]() |
Alpha-Methylacyl-Coa Racemase From Mycobacterium Tuberculosis In Complex With Fenoprofenoyl-Coa
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ISOMERASE Ligands: A1IY9 |
![]() |
Alpha-Methylacyl-Coa Racemase From Mycobacterium Tuberculosis In Complex With Flurbiprofenoyl-Coa
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ISOMERASE Ligands: A1IZA |
![]() |
Alpha-Methylacyl-Coa Racemase From Mycobacterium Tuberculosis In Complex With Naproxenoyl-Coa
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ISOMERASE Ligands: A1I1O |
![]() |
Alpha-Methylacyl-Coa Racemase From Mycobacterium Tuberculosis In Complex With 2-Methyldecanoyl-Coa
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ISOMERASE Ligands: A1IZB |
![]() |
Alpha-Methylacyl-Coa Racemase From Mycobacterium Tuberculosis In Complex With Ketoprofenoyl-Coa
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ISOMERASE Ligands: A1IZD |
![]() |
Alpha-Methylacyl-Coa Racemase From Mycobacterium Tuberculosis In Complex With Acetyl-Coa
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ISOMERASE Ligands: ACO |
![]() |
Alpha-Methylacyl-Coa Racemase From Mycobacterium Tuberculosis In Complex With Isobutanoyl-Coa
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ISOMERASE Ligands: CO6 |
![]() |
Alpha-Methylacyl-Coa Racemase From Mycobacterium Tuberculosis In Complex With Butanoyl-Coa
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-06-11 Classification: ISOMERASE Ligands: BCO |




















